Amylyx Pharmaceuticals (AMLX) Return on Sales: 2023-2024
Historic Return on Sales for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Dec 2024 value amounting to -2.59%.
- Amylyx Pharmaceuticals' Return on Sales fell 270.00% to -2.59% in Q4 2024 from the same period last year, while for Dec 2024 it was -2.59%, marking a year-over-year decrease of 270.00%. This contributed to the annual value of -2.64% for FY2024, which is 275.00% down from last year.
- According to the latest figures from Q4 2024, Amylyx Pharmaceuticals' Return on Sales is -2.59%, which was down 116.20% from -1.20% recorded in Q3 2024.
- Over the past 5 years, Amylyx Pharmaceuticals' Return on Sales peaked at 0.11% during Q4 2023, and registered a low of -2.59% during Q4 2024.
- Its 2-year average for Return on Sales is -0.75%, with a median of -0.42% in 2024.
- Over the last 5 years, Amylyx Pharmaceuticals' Return on Sales had its largest YoY gain of 118bps in 2024, and its largest YoY loss of 270bps in 2024.
- Quarterly analysis of 2 years shows Amylyx Pharmaceuticals' Return on Sales stood at 0.11% in 2023, then tumbled by 270bps to -2.59% in 2024.
- Its Return on Sales stands at -2.59% for Q4 2024, versus -1.20% for Q3 2024 and -0.51% for Q2 2024.